Eligibility Criteria Eligibility criteria for all target trials included a prior diagnosis of type 2 diabetes, a recent medical encounter for type 2 diabetes diagnosis in the past year ( active type 2 diabetes ), prescriptions of antidiabetic medications (semaglutide, tirzepatide, or other antidiabetic medications) between December 2017 and January 2023, and diagnosis with at least 1 condition among the prescription guidelines for semaglutide and tirzepatide (eg, obesity, hypertension, hypercholesterolemia, heart disease, stroke, kidney disease, or an A 1C level 8.5%)
We absolutely do not recommend this
Then, she had Mirena implanted when she was 30 years old, and the small, t-shaped IUD eroded her health slowly over the next 10 years
Electrostatic Origin of the Catalytic Power of Enzymes and the Role of Preorganized Active Sites